|
previous - ISSUE - next  |
 |
 |  |
|
Contents: Volume 5, Number S1
|
|
 |
  |
  |
 |
Degrees of Risk.
Holger Breithaupt, Frank Gannon & Caroline Hadley
EMBO reports 5, S1, S1–S3 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400265 |
 |
 |
 |
Science policy for risk governance. Rather than regarding risk governance as a burden, science should embrace it as an opportunity to build public trust
José Mariano Gago
EMBO reports 5, S1, S4–S6 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400264 |
 |
 |
 |
Pascal's legacy. The musings of a Belgian monk 300 years ago on the consequences of believing in God, or not, have influenced our Western life probably more than any other scientific or technological invention
John F. Ross
EMBO reports 5, S1, S7–S10 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400229 |
 |
 |
 |
Globalization and risks to health. As borders disappear, people and goods are increasingly free to move, creating new challenges to global health. These cannot be met by national governments alone but must be dealt with instead by international organizations and agreements
Tikki Pang & G. Emmanuel Guindon
EMBO reports 5, S1, S11–S16 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400226 |
 |
 |
 |
The real and perceived risks of genetically modified organisms. The debate about the potential risks of genetically modified organisms has lasted for almost three decades without any final conclusion in sight. Why is it that the public remains critical of this technology even though science has so far not demonstrated any tangible risks to human health and the environment?
Helge Torgersen
EMBO reports 5, S1, S17–S21 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400231 |
 |
 |
 |
The prediction of disease risk in genomic medicine. Scientific prospects and implications for public policy and ethics
Wayne D. Hall, Katherine I. Morley & Jayne C. Lucke
EMBO reports 5, S1, S22–S26 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400224 |
 |
 |
 |
The risks of eating and drinking. Consumer perceptions and 'reality'
Susan B.T. Wilkinson, Gene Rowe & Nigel Lambert
EMBO reports 5, S1, S27–S31 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400225 |
 |
 |
 |
The case of nanobiotechnology. Towards a prospective risk assessment
Armin Grunwald
EMBO reports 5, S1, S32–S36 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400223 |
 |
 |
 |
Hormesis: a revolution in toxicology, risk assessment and medicine. Re-framing the dose–response relationship
Edward J. Calabrese
EMBO reports 5, S1, S37–S40 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400222 |
 |
 |
 |
Systemic risks: a new challenge for risk management. As risk analysis and risk management get increasingly caught up in political debates, a new way of looking at and defining the risks of modern technologies becomes necessary
Ortwin Renn & Andreas Klinke
EMBO reports 5, S1, S41–S46 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400227 |
 |
 |
 |
Principles of risk perception applied to gene technology. To overcome the resistance to applications of biotechnology, research on risk perception must take a closer look at the public's reasons for rejecting this technology
Lennart Sjöberg
EMBO reports 5, S1, S47–S51 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400258 |
 |
 |
 |
Science in a political environment. The dynamics of research, risk perception and policy making
Peter Weingart
EMBO reports 5, S1, S52–S55 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400230 |
 |
 |
 |
The consequences of fear. Our modern world is a risky place and evokes many well-founded fears. But these fears themselves create a new risk for our health and well-being that needs to be addressed
David Ropeik
EMBO reports 5, S1, S56–S60 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400228 |
 |
 |
 |
When even the 'best-laid' plans go wrong. Strategic risk communication for new and emerging risks
Katherine McComas
EMBO reports 5, S1, S61–S65 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400257 |
 |
 |
 |
Risk and the law. Scientists do not necessarily like the restrictions and regulations of biotechnology, but they need to accept that lawmakers must reflect the wishes and demands of the majority of the population, who are increasingly aware of the potential risks
Julian Kinderlerer
EMBO reports 5, S1, S66–S70 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400259 |
 |
top   |
 |